Molecular Diagnostics Market Research Report, By Technology, Product & Services, End Users, Application And Geography – Global Market Share, Trend Analysis And Forecast Up To 2023

Report Code: 1348
Publish Date: September 2017

  Corporate License($4200)

  Single User License($3700)

Product Description

Molecular Diagnostics market is mainly segmented on the basis of type of Technology, Products and Services, End Users, Applications and by Region/Country. On the basis of Technology, the market is segmented into Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization (In Situ Hybridization and FISH), DNA Sequencing and NGS, Microarray and Others. The market is further segmented into Products and Services of molecular diagnostics such as, Reagents & Kits, Instruments and Software & Services. The market by End Users is segmented as Hospitals, Diagnostics Laboratories, Academic Research Institutes and Others which include blood banks etc. The molecular diagnostics market finds its application in Infectious Disease, Oncology, Pharmacogenomics, Microbiology, Genetic Disease Screening, Human Leukocyte Antigen Typing and Blood Screening.

Polymerase Chain Reaction (PCR)tecnology dominates the molecular diagnostics market followed by Isothermal Nucleic Acid Amplification Technology (INAAT) technology. DNA Sequencing and NGS and Microarray technologies are growing at a highest pace due to wide acceptance of personalize medicines. 
The factors driving the global molecular diagnostics market are, growing prevalence of infectious diseases, increasing risk of various type of cancers etc.

The report includes market size estimation for regions such as Americas, Europe, Asia-Pacific and Middle East & Africa. Key companies which lead the Molecular Diagnostics market are profiled in the report such as Abbott Laboratories, Qiagen N.V. , Roche Diagnostics, Hologic, Inc. , Grifols , Siemens Healthcare , Becton, Dickinson and Company , Beckman Coulter Inc. (subsidiary of Danaher Corporation), Biomérieux SA and Cepheid Inc. The company profiles includes business overview of the company, financial highlights, products and recent developments related to Molecular Diagnostics market.

Request for sample report...
Axiom MRC’s Qual-Quant data modeling tool is an in-house developed tool, which is based on the fundamentals such as Top Down and Bottom Up approaches. The data model compares Immunoassay, Clinical Chemistry, Clinical Microbiology, Molecular Diagnostics, Hematology etc. markets to estimate and validate the qualitative and quantitative findings across various countries. It also allows to analyze the market value chain in comparison with main market i.e. global in vitro diagnostics market to arrive at holistic and factual findings of the markets.